Found: 62
Select item for more details and to access through your institution.
Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 1, p. 40, doi. 10.1002/ijc.35097
- By:
- Publication type:
- Article
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e2008, doi. 10.1210/clinem/dgab933
- By:
- Publication type:
- Article
Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3720, doi. 10.3390/jcm9113720
- By:
- Publication type:
- Article
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24482-1
- By:
- Publication type:
- Article
Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 9, p. 1111, doi. 10.1111/apt.17931
- By:
- Publication type:
- Article
Editorial: moving from the clinic towards population hepatology—authorsʼ reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Letter: comment on Park et al – the association of non‐alcoholic fatty liver disease between parents and adolescent children.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 737, doi. 10.1111/apt.17390
- By:
- Publication type:
- Article
Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 4, p. 418, doi. 10.1111/apt.17374
- By:
- Publication type:
- Article
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 2, p. 234, doi. 10.1111/apt.16720
- By:
- Publication type:
- Article
Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0294695
- By:
- Publication type:
- Article
Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
- Published in:
- Gastroenterology Research & Practice, 2018, p. 1, doi. 10.1155/2018/1942648
- By:
- Publication type:
- Article
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
- Published in:
- BMC Gastroenterology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12876-021-02017-8
- By:
- Publication type:
- Article
Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019.
- Published in:
- European Journal of Epidemiology, 2023, v. 38, n. 9, p. 973, doi. 10.1007/s10654-023-01028-x
- By:
- Publication type:
- Article
Vascular Complications in Patients with Chronic Pancreatitis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3720, doi. 10.3390/jcm10163720
- By:
- Publication type:
- Article
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01255
- By:
- Publication type:
- Article
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 15, p. 1287, doi. 10.1001/jama.2024.1447
- By:
- Publication type:
- Article
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Liver International, 2024, v. 44, n. 11, p. 3050, doi. 10.1111/liv.16091
- By:
- Publication type:
- Article
Persons with metabolic dysfunction‐associated steatotic liver disease are at increased risk of severe depression.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2551, doi. 10.1111/liv.16019
- By:
- Publication type:
- Article
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14414 patients.
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1689, doi. 10.1111/liv.15919
- By:
- Publication type:
- Article
Statin initiation after myocardial infarction in patients with alcohol‐related liver disease: A nationwide population‐based study.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 2002, doi. 10.1111/liv.15912
- By:
- Publication type:
- Article
Risk of major adverse liver outcomes among first‐degree relatives of individuals with MASLD.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1253, doi. 10.1111/liv.15874
- By:
- Publication type:
- Article
Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2142, doi. 10.1111/liv.15680
- By:
- Publication type:
- Article
Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2186, doi. 10.1111/liv.15663
- By:
- Publication type:
- Article
Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis.
- Published in:
- Liver International, 2023, v. 43, n. 4, p. 763, doi. 10.1111/liv.15526
- By:
- Publication type:
- Article
Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2769, doi. 10.1111/liv.15438
- By:
- Publication type:
- Article
Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study.
- Published in:
- Liver International, 2022, v. 42, n. 4, p. 820, doi. 10.1111/liv.15195
- By:
- Publication type:
- Article
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 545, doi. 10.1111/liv.14792
- By:
- Publication type:
- Article
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
- Published in:
- Liver International, 2019, v. 39, n. 6, p. 1098, doi. 10.1111/liv.14087
- By:
- Publication type:
- Article
Cardiovascular risk factors in non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 197, doi. 10.1111/liv.13973
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2082, doi. 10.1111/liv.13751
- By:
- Publication type:
- Article
Quality of life as a prognostic factor for survival in hepatocellular carcinoma.
- Published in:
- Liver International, 2018, v. 38, n. 5, p. 885, doi. 10.1111/liv.13593
- By:
- Publication type:
- Article
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up.
- Published in:
- Liver International, 2016, v. 36, n. 11, p. 1688, doi. 10.1111/liv.13144
- By:
- Publication type:
- Article
Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease.
- Published in:
- Liver International, 2016, v. 36, n. 2, p. 268, doi. 10.1111/liv.12902
- By:
- Publication type:
- Article
Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1186097
- By:
- Publication type:
- Article
Association between temperature, sunlight hours and alcohol consumption.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0223312
- By:
- Publication type:
- Article
Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
- Published in:
- American Journal of Epidemiology, 2022, v. 191, n. 2, p. 298, doi. 10.1093/aje/kwab119
- By:
- Publication type:
- Article
Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis.
- Published in:
- Molecular Systems Biology, 2024, v. 20, n. 4, p. 374, doi. 10.1038/s44320-024-00024-x
- By:
- Publication type:
- Article
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD.
- Published in:
- Journal of Internal Medicine, 2024, v. 296, n. 2, p. 177, doi. 10.1111/joim.13813
- By:
- Publication type:
- Article
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 537, doi. 10.1111/joim.13679
- By:
- Publication type:
- Article
Increased risk for microvascular outcomes in NAFLD—A nationwide, population‐based cohort study.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 2, p. 216, doi. 10.1111/joim.13673
- By:
- Publication type:
- Article
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort study.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 2, p. 164, doi. 10.1111/joim.13624
- By:
- Publication type:
- Article
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 2, p. 184, doi. 10.1111/joim.13570
- By:
- Publication type:
- Article
Risk of fractures and subsequent mortality in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 3, p. 492, doi. 10.1111/joim.13497
- By:
- Publication type:
- Article
Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 2, p. 177, doi. 10.1111/joim.13343
- By:
- Publication type:
- Article
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
- Published in:
- Journal of Internal Medicine, 2022, v. 291, n. 6, p. 824, doi. 10.1111/joim.13463
- By:
- Publication type:
- Article
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum].
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden.
- Published in:
- Clinical Epidemiology, 2021, v. 13, p. 21, doi. 10.2147/CLEP.S282475
- By:
- Publication type:
- Article
Incidence of ICD-Based Diagnoses of Alcohol-Related Disorders and Diseases from Swedish Nationwide Registers and Suggestions for Coding.
- Published in:
- Clinical Epidemiology, 2020, v. 12, p. 1433, doi. 10.2147/CLEP.S285936
- By:
- Publication type:
- Article
Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
- Published in:
- 2018
- By:
- Publication type:
- journal article